Cellectis
  • About
    Our mission
    Governance
    Partners
  • Science
    Our Genome Engineering Platform
    TALEN® Technology
    In-House Manufacturing
  • Pipeline
    Product Candidates
  • Investors
    IR Overview
    News
    • Press releases
    • Events and Webcasts
    Presentations
    • Corporate presentations
    • Scientific presentations
    • Scientific publications
    Corporate Governance
    • Board of Directors
    • Executive Committee
    • External Auditors
    • Governance Documents
    • General meetings
    Financial Information
    • SEC filings
    • Financial statements
    • Voting Rights & Share Capital
    • Stock information
    Shareholders Services
    • IR Inquiries
    • IR FAQ
  • Careers
    Our culture
    Job opportunities
  • Contact us
LinkedinX FR
› Events
  • About
    • Our mission
    • Governance
    • Partners
  • Science
    • Our Genome Engineering Platform
    • TALEN® Technology
    • In-House Manufacturing
  • Pipeline
    • Product Candidates
  • Investors
    • IR Overview
    • News
      • Press releases
      • Events and Webcasts
    • Presentations
      • Corporate presentations
      • Scientific presentations
      • Scientific publications
    • Corporate Governance
      • Board of Directors
      • Executive Committee
      • External Auditors
      • Governance Documents
      • General meetings
    • Financial Information
      • SEC filings
      • Financial statements
      • Voting Rights & Share Capital
      • Stock information
    • Shareholders Services
      • IR Inquiries
      • IR FAQ
  • Careers
    • Our culture
    • Job opportunities
  • Contact us
FR
LinkedinX

Events

All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
May 13, 2025 - May 17, 2025

28th American Society of Gene and Cell Therapy Annual Meeting (ASGCT)

Read more
April 10, 2025

The 2nd CRISPR Medicine Conference 2025

Read more
April 7, 2025

Expert Access – Revolutionizing cancer treatment: the potential of allogeneic CAR T

Read more
April 3, 2025

The Van Lanschot Kempen Life Sciences Conference

Read more
March 16, 2025 - February 20, 2025

Keystone: Immune Cell Therapies: Advances in Cancer and Autoimmune Diseases

Read more
March 14, 2025 - March 15, 2025

Cellectis Q4 & full year 2024 earnings call

Read more
March 12, 2025 - March 14, 2025

4th Annual Cell Therapy Potency Assay Summit

Read more
March 12, 2025 - March 15, 2025

SITC Spring Scientific, Cellular Therapy for Solid Tumors

Read more
March 11, 2025 - March 13, 2025

Barclays 27th Annual Global Healthcare Conference

Read more
March 10, 2025 - March 12, 2025

Genome Editing Towards Therapies

Read more

Posts pagination

← PREV 1 2 3 4 NEXT →

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US
cellectis

Clinical-stage biotech · Dual-listed on Nasdaq (CLLS) and Euronext Growth (ALCLS).
Paris · New York · Raleigh.

  • ABOUT
    • Our mission
    • Governance
    • Partners
  • SCIENCE
    • Our Genome Engineering Platform
    • TALEN® Technology
    • In-House Manufacturing
  • PIPELINE
    • Product Candidates
  • INVESTORS
    • Events
    • Corporate presentations
    • Scientific presentations
    • Scientific publications
    • Governance Documents
    • ESG report
    • Shareholders Meetings
    • SEC filings
    • Financial statements
    • Voting Rights & Share Capital
    • Stock information
    • PDMR Notifications
    • IR Inquiries
    • IR FAQ
  • Careers
    • Our culture
    • Job opportunities
© 2026 Cellectis — All rights reserved
  • Legal notice
  • Community Guidelines